A Maui Derm 2026 session explored advancements in pediatric dermatology, emphasizing precision medicine and targeted therapies for children.
A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous adverse reactions such as Stevens–Johnson syndrome (SJS) and toxic ...
Postmarket surveillance data revealed that enfortumab vedotin (EV) skin toxicity is associated with high hospitalization and mortality rates, especially with Stevens-Johnson syndrome/toxic epidermal ...
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) survivors encounter rare, life-threatening drug reactions and years of physical, emotional and social consequences long after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results